NCT00000219View on ClinicalTrials.gov

Buprenorphine Dose Alteration Study - 1

PHASE1CompletedINTERVENTIONAL
0
Timeline

Start Date

December 31, 1991

Study Completion Date

July 31, 2001

Conditions
Opioid-Related Disorders
Interventions
DRUG

Buprenorphine

Trial Locations (1)

05401

Treatment Research Center, Burlington

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of Vermont

OTHER

NCT00000219 - Buprenorphine Dose Alteration Study - 1 | Biotech Hunter | Biotech Hunter